Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -80,902 | -62,879 | -48,374 | -31,912 | -88,275 |
| Depreciation Amortization | 238 | 191 | 113 | 55 | 83 |
| Accounts payable and accrued liabilities | 1,194 | 531 | 976 | 357 | -277 |
| Other Working Capital | 795 | -1,679 | 1,402 | -736 | -1,975 |
| Other Operating Activity | 26,308 | 24,217 | 21,658 | 18,288 | 39,261 |
| Operating Cash Flow | $-52,367 | $-39,619 | $-24,225 | $-13,948 | $-51,183 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -12 | -12 | N/A | -39 |
| Investing Cash Flow | $-12 | $-12 | $-12 | $N/A | $-39 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -5,438 |
| Common Stock Issued | 8,901 | 1,140 | N/A | N/A | 98,176 |
| Financing Cash Flow | $8,901 | $1,140 | $N/A | $N/A | $92,738 |
| Exchange Rate Effect | 5 | -23 | -58 | -46 | -34 |
| Beginning Cash Position | 147,828 | 147,828 | 147,828 | 147,828 | 106,346 |
| End Cash Position | 104,355 | 109,314 | 123,533 | 133,834 | 147,828 |
| Net Cash Flow | $-43,473 | $-38,514 | $-24,295 | $-13,994 | $41,482 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,367 | -39,619 | -24,225 | -13,948 | -51,183 |
| Capital Expenditure | -12 | -12 | -12 | N/A | -39 |
| Free Cash Flow | -52,379 | -39,631 | -24,237 | -13,948 | -51,222 |